simendan has been researched along with Emergencies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boldt, J; Isgro, F; Kiessling, AH; Lehmann, A; Thaler, E; Zeitler, C | 1 |
| Ghazwinian, N; Hochmair, N; Mueller, T; Plöchl, W; Ponschab, M | 1 |
2 other study(ies) available for simendan and Emergencies
| Article | Year |
|---|---|
Levosimendan in patients with acute myocardial ischaemia undergoing emergency surgical revascularization.
Topics: Acute Disease; Aged; Anti-Arrhythmia Agents; Blood Pressure; Case-Control Studies; Catecholamines; Cohort Studies; Coronary Artery Bypass; Emergencies; Female; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Intra-Aortic Balloon Pumping; Length of Stay; Male; Middle Aged; Monitoring, Intraoperative; Myocardial Ischemia; Myocardial Revascularization; Pyridazines; Respiration, Artificial; Retrospective Studies; Shock, Cardiogenic; Simendan; Survival Rate; Vascular Resistance | 2008 |
Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
Topics: Aged; Aged, 80 and over; Cardiac Output, Low; Cardiotonic Agents; Emergencies; Female; Heart Failure; Hemodynamics; Hip Fractures; Humans; Hydrazones; Infusions, Intravenous; Male; Natriuretic Peptides; Patient Selection; Preoperative Care; Pyridazines; Simendan; Survival Rate; Time Factors; Treatment Outcome; Troponin | 2008 |